We investigated the relationship of codon 972 polymorphism of the insulin r
eceptor substrate-1 (IRS-1) gene with insulin resistance in the Japanese po
pulation. Among 130 patients with type-2 diabetes mellitus (DM), we identif
ied 6 who were heterozygous for the Gly972Arg mutation. Among 744 healthy s
ubjects, 6 were heterozygous and 1 was homozygous for the mutation. A hyper
insulinemic euglycemic clamp study was performed in 3 of 6 diabetic patient
s with the heterozygous Gly972Arg mutation and in 60 without it. Both group
s showed almost the same levels of insulin sensitivity (glucose infusion ra
te, GIR = 50.2 +/- 3.0 vs. 51.3 +/- 12.1 mu mol/kg/min). Similarly, there w
as no difference in insulin sensitivity between healthy subjects with and w
ithout the mutation using the homeostasis model assessment (HOMA index = 1.
14 +/- 0.50 vs. 1.02 +/- 0.63). The frequency of the Gly972Arg allele was n
ot increased in diabetic patients compared with control subjects even in ag
ed (>50 years old) or obese (BMI greater than or equal to 25) subjects. Amo
ng healthy subjects, we identified a 25-year-old male with the homozygous G
ly972Arg allele. He was slightly obese (BMI = 25.5) but showed relatively h
igh insulin sensitivity, almost equal to that of healthy subjects without t
he mutation (GIR = 67.2 vs. 71.8 +/- 22.0 mu mol/kg/min). Because the GIR i
n healthy subjects was significantly higher compared with that in type-2 DM
patients, we speculate that another genetic or environmental factor produc
ing a more deleterious effect on insulin sensitivity may exist in diabetic
patients. We conclude that this gene abnormality does not play a role in th
e pathogenesis of insulin resistance and type-2 DM. Copyright (C) 2000 S. K
arger AG. Basel.